About this trial
The Investigators are studying the effect of an ACL reconstruction on return to play by capturing outcome measures and biomechanics information.
Eligibility criteria
Qualifiers
Patients must be age 14-26 years old.
Skeletally mature patients, with an ACL deficient knee who desire to have ACL reconstructive surgery using autograft augmentation.
Patients must be a tanner stage of 5 and a posteroanterior left hand film x-ray will be obtained to confirm bone age and skeletal maturity
Patients with associated meniscal and chondral pathology (except patients falling into
Disqualifiers
An understanding of the purpose of the study and providing written informed consent.
Patients with multi-ligament surgery (MCL, PCL, LCL, PMC, or PLC repair or reconstruction),
Patients who have undergone previous ACL reconstructive surgery.
Patients who are currently pregnant or nursing.
Trial design
Treatments tested in this trial
- Fertilized ACL
Treatment groups
Sponsors and collaborators
Marshall University
Lead sponsor
Arthrex, Inc.
Collaborator